Investors

Growing Shareholder Value

Press Releases

Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification

Oct 11, 2018
Read More

Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival

Sep 24, 2018
Read More

Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018

Sep 19, 2018
Read More

Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated

Jul 26, 2018
Read More

Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year

Jul 26, 2018
Read More

Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification

Jul 06, 2018
Read More

Abiomed to Present at the Jefferies 2018 Healthcare Conference

May 29, 2018
Read More

Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year

May 03, 2018
Read More

Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification

Apr 13, 2018
Read More

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Apr 04, 2018
Read More
View all